Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision
{{output}}
Randomized controlled trials in oncology often allow control group participants to switch to experimental treatments, a practice that, while often ethically necessary, complicates the accurate estimation of long-term treatment effects. When switching rates are... ...
